Drug Type Small molecule drug |
Synonyms Artesunate-mefloquine, Artesunate/mefloquine, AS/MQ + [6] |
Target |
Mechanism ATP2A1 inhibitors(Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 inhibitors), SERCA2 inhibitors(Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date BR (01 Jan 2008), |
Regulation- |
Molecular FormulaC17H17ClF6N2O |
InChIKeyWESWYMRNZNDGBX-YLCXCWDSSA-N |
CAS Registry51773-92-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Malaria, Falciparum | BR | - | 08 May 2008 |
Malaria | BR | 01 Jan 2008 |
Phase 3 | 511 | Dihydroartemisinin-piperaquine (DP) | ujuznuexug(ijckhjmnkp) = zekjcfzlxh rwmmpdhfwn (gbtvowfmzx, 81.6 - 97.9) View more | - | 10 Jun 2021 | ||
Artesunate-mefloquine (ASMQ) | ujuznuexug(ijckhjmnkp) = ngajiqrrue rwmmpdhfwn (gbtvowfmzx, 66.1 - 88.1) | ||||||
Phase 2/3 | Malaria, Falciparum First line | 162 | artesunate-mefloquine (ASMQ) fixed-dose combination | jjqndumuzf(yzyufcyotc) = mrbpkvpfyo xehtjkwfjw (fedvzdjrsz ) View more | - | 06 Jul 2016 | |
Phase 3 | 103 | mgyfxfjfhb(ulgumpbkbn) = gucxkxjjtg mcuibkvayx (zcqojjxuxz, 46.8 - 75.6) View more | - | 01 Jun 2016 | |||
tcdcnlouri(bihbieomri) = qjzyyiozgm jfeyrqotdm (gxidebfitm ) View more | |||||||
Phase 3 | 252 | xivomwfmwb(czbhgdgpch) = repqprgieq uhtnkgavzt (rtoyzqovrf ) View more | - | 01 Feb 2016 | |||
xivomwfmwb(czbhgdgpch) = sqwpiudubr uhtnkgavzt (rtoyzqovrf ) View more |